NRAS and acute myeloid leukemia: While RAS mutations appear to play a pivotal role in the transformation of CMML to AML, only NRAS mutations seem to exhibit a significant association with adverse clinical outcomes and are included in dedicated scores such as CPSS-Mol score, as well as the CMML transplant score.